AGTC to Present at the 2021 Wells Fargo Virtual Healthcare Conference
September 02, 2021 09:41 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
Greater Gift, AGTC, and 2020 On-site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams to Underserved Children in the Local Community
August 24, 2021 08:00 ET
|
Applied Genetic Technologies Corporation
WINSTON SALEM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Greater Gift of Winston Salem, a non-profit that celebrates participation in clinical trials today announced a partnership with Applied Genetic...
AGTC Announces Sponsorship of Achroma Corp’s No Roadblocks Program
August 19, 2021 16:05 ET
|
Applied Genetic Technologies Corporation
-Program helps those living with Achromatopsia receive filtered glasses and contact lenses to qualify for bioptic driving- GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 19, 2021 (GLOBE NEWSWIRE)...
AGTC Appoints Ophthalmology and Retinal Disease Specialist and Industry R&D Veteran Yehia Hashad, MD to its Board of Directors
August 18, 2021 08:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC to Participate in Envision Virtual Conference East 2021 Panel Discussion
August 16, 2021 08:00 ET
|
Applied Genetic Technologies Corporation
-AGTC patient advocacy executive director will address genetic testing and gene therapy for the treatment of rare retinal diseases- GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 16, 2021 (GLOBE...
AGTC to Participate at Upcoming Investor Conferences
August 02, 2021 16:05 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC to Host Virtual R&D Day on July 22, 2021
July 08, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
Widely Recognized Experts and AGTC Leadership Will Expand on Recent ACHM Phase 1/2 Clinical Trial Data and Discuss XLRP Milestones Webcast Scheduled from 10:00 am - 1:00 pm ET GAINESVILLE, Fla. and...
AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients with Mutations in the ACHM B3 Gene
June 24, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
- Activities to support the next stage of clinical development of ACHM B3 candidate are ongoing- - Dosing of pediatric patients in ACHM B3 program and ACHM A3 program is expected to be completed in...
AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials
June 23, 2021 16:03 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 23, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC to Present at American Optometric Association’s Optometry’s Meeting
June 22, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
-AGTC patient advocacy executive director will highlight the state of gene therapy trial recruitment for IRDs- GAINESVILLE, Fla. and CAMBRIDGE, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Applied...